Clinical Trial Update: The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating minocycline for negative symptoms in schizophrenia, including extent and potential mechanisms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: University of Manchester | Conditions: Schizophrenia and Disorders With Psychotic Features | Phase 2 | Status: COMPLETED